GRRMF (Gerresheimer AG) Long-Term Debt: $1,756 Mil (As of Nov. 2025)


GRRMF Gerresheimer AG GRRMF
58 GF Score
Price $33.35
GF Value $115.44
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Gerresheimer AG Long-Term Debt?

Gerresheimer AG GRRMF 58 Long-Term Debt is $1,756 Mil as of Nov. 2025. GuruFocus rates GRRMF with a GF Score™ of 58/100 and a GF Value™ of $115.44 (Possible Value Trap). The stock has 6 warning signs investors should review.

Gerresheimer AG's Long-Term Debt for the quarter that ended in Nov. 2025 was $1,756 Mil.

Gerresheimer AG's quarterly Long-Term Debt stayed the same from May. 2025 ($0 Mil) to Aug. 2025 ($0 Mil) but then increased from Aug. 2025 ($0 Mil) to Nov. 2025 ($1,756 Mil).

Gerresheimer AG's annual Long-Term Debt increased from Nov. 2023 ($663 Mil) to Nov. 2024 ($924 Mil) and increased from Nov. 2024 ($924 Mil) to Nov. 2025 ($1,756 Mil).

Gerresheimer AG  (OTCPK:GRRMF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Gerresheimer AG Long-Term Debt Related Terms

Gerresheimer AG Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Gerresheimer AG's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG Long-Term Debt Chart

Gerresheimer AG Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 747.72 650.95 663.22 924.42 1,756.16

Gerresheimer AG Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 924.42 0.00 0.00 0.00 1,756.16
GRRMF
58GF Score
Gerresheimer AG GRRMF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $1,756 Mil mean?
Gerresheimer AG (GRRMF) has a Long-Term Debt of $1,756 Mil as of Nov. 2025.
Is Gerresheimer AG's Long-Term Debt too high?
Gerresheimer AG's current Long-Term Debt is $1,756 Mil. Overall, Gerresheimer AG has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Long-Term Debt compare to ISRG and BDX?
Gerresheimer AG's Long-Term Debt of $1,756 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Gerresheimer AG's current Long-Term Debt is $1,756 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $115.44, compared to a current price of $33.35 — trading 71.1% below its estimated fair value. The current Long-Term Debt is $1,756 Mil. Gerresheimer AG's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current Long-Term Debt is $1,756 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gerresheimer AG (GRRMF) Overvalued in 2026?

Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued. The current stock price of $33.35 is trading 71.1% below its estimated GF Value™ of $115.44. GuruFocus considers Gerresheimer AG to be Possible Value Trap.

Key valuation signals for GRRMF:

  • Long-Term Debt: $1,756 Mil
  • GF Value™: $115.44 vs. price of $33.35 (71.1% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gerresheimer AG Business Description

Address Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
58GF Score

Get the complete analysis for GRRMF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.35
Price
$115.44
GF Value